Haisco Pharmaceutical Group Co.,Ltd — Investor Relations & Filings
Haisco Pharmaceutical Group Co.,Ltd. focuses on the research, development, production, and commercialization of innovative drugs and high-end generic pharmaceuticals. The company maintains a specialized portfolio across therapeutic areas including anesthesia, parenteral nutrition, anti-infection, cardiovascular health, and endocrine disorders. Key products include advanced anesthetic agents and specialized nutritional injections designed for clinical use. Haisco prioritizes technological innovation through a dedicated R&D infrastructure, targeting the development of small molecule chemical drugs and complex delivery systems. Its operations emphasize high-standard manufacturing processes and the integration of clinical research to address complex medical requirements. The company aims to provide therapeutic solutions that enhance patient care through a commitment to scientific excellence and product quality.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于获得创新药注射用HSK55718IND申请《受理通知书》的公告 | 2025-10-13 | Chinese | |
| 关于获得创新药HSK36357胶囊新适应症IND申请《受理通知书》的公告 | 2025-10-09 | Chinese | |
| 中信证券股份有限公司关于海思科医药集团股份有限公司向特定对象发行A股股票之发行保荐书 | 2025-09-25 | Chinese | |
| 2025年度向特定对象发行A股股票募集说明书（修订稿） | 2025-09-25 | Chinese | |
| 中信证券股份有限公司关于海思科医药集团股份有限公司向特定对象发行A股股票之上市保荐书 | 2025-09-25 | Chinese | |
| 北京市中伦律师事务所关于海思科医药集团股份有限公司2025年度向特定对象发行A股股票的补充法律意见书（三） | 2025-09-25 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 36672363 | 关于获得创新药注射用HSK55718IND申请《受理通知书》的公告 | 2025-10-13 | Chinese | ||
| 36672351 | 关于获得创新药HSK36357胶囊新适应症IND申请《受理通知书》的公告 | 2025-10-09 | Chinese | ||
| 36672346 | 中信证券股份有限公司关于海思科医药集团股份有限公司向特定对象发行A股股票之发行保荐书 | 2025-09-25 | Chinese | ||
| 36672301 | 2025年度向特定对象发行A股股票募集说明书（修订稿） | 2025-09-25 | Chinese | ||
| 36672224 | 中信证券股份有限公司关于海思科医药集团股份有限公司向特定对象发行A股股票之上市保荐书 | 2025-09-25 | Chinese | ||
| 36672201 | 北京市中伦律师事务所关于海思科医药集团股份有限公司2025年度向特定对象发行A股股票的补充法律意见书（三） | 2025-09-25 | Chinese | ||
| 36672189 | 关于募集说明书等申请文件更新的提示性公告 | 2025-09-25 | Chinese | ||
| 36672177 | 信息披露暂缓与豁免制度 | 2025-09-23 | Chinese | ||
| 36672168 | 关于2025年度向特定对象发行A股股票预案（修订稿）披露的提示性公告 | 2025-09-23 | Chinese | ||
| 36672160 | 2025年度向特定对象发行A股股票募集资金使用的可行性分析报告（修订稿） | 2025-09-23 | Chinese | ||
| 36672153 | 内部审计制度 | 2025-09-23 | Chinese | ||
| 36672137 | 关于2025年度向特定对象发行A股股票预案修订情况说明的公告 | 2025-09-23 | Chinese | ||
| 36672130 | 关于2025年度向特定对象发行股票摊薄即期回报及采取填补措施和相关主体承诺（修订稿）的公告 | 2025-09-23 | Chinese | ||
| 36672114 | 第五届董事会第三十次会议决议公告 | 2025-09-23 | Chinese | ||
| 36672103 | 2025年度向特定对象发行A股股票方案论证分析报告（修订稿） | 2025-09-23 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Haisco Pharmaceutical Group Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54674/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54674 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54674 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54674 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54674}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Haisco Pharmaceutical Group Co.,Ltd (id: 54674)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.